Tagesarchiv

Pressemitteilung Pictet Asset Management: „Immovable objects, irresistible forces“

Pictet | Frankfurt,04.10.2018. Sehr geehrte Damen und Herren, anbei erhalten Sie den monatlichen Investor-Outlook von Pictet Asset Management mit dem Titel „Immovable objects, irresistible forces“ mit folgender Kernaussage: “Equity markets are likely to be held in check by simmering trade tensions and tighter monetary conditions, even if corporate profits remain healthy.”

Lesen Sie mehr »

Pressemitteilung Pictet Asset Management: Luca Paolini: Time to dial down equities

Pictet | Frankfurt, 09.06.2016. “Economic momentum is slowing worldwide at a time when there is political upheaval in Europe and growing uncertainty over the direction of US and Chinese monetary policy,” says Pictet Asset Management’s chief strategist Luca Paolini. “Against this volatile backdrop, we have cut our equity exposure to neutral from overweight. We upgrade gold, a defensive asset that tends to do well in volatile times, to overweight from neutral. We remain underweight in bonds. Overall, we have reduced …

Lesen Sie mehr »

Pressemitteilung Bellevue Asset Management AG: BB Biotech: Monthy News December 2015

Bellevue | Küsnacht, 11.01.2016. MARKET REVIEW The Nasdaq Biotech Index (NBI) ended the month of December up +1.3% in USD. BB Biotech’s NAV was up +0.2% in USD, -3.4% in CHF and down -3.0% in EUR. BB Biotech’s share price was up +2.6% in USD and lost -0.7% in EUR and -1.2% in CHF. 2015 was another year of outperformance for biotechnology versus general equity markets, with the Nasdaq Biotech Index NBI (+11.8% in USD) outperforming the S&P500 (+1.4% in USD) by +10%. BB Biotech …

Lesen Sie mehr »